Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression
Z Shi, X Wang, J Wang, H Chen, Q Du, Y Lang… - Journal of …, 2023 - Springer
Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
autoimmune responses in central nervous system. Patients begin with a relapsing–remitting …
Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis
BJE Raveney, W Sato, D Takewaki… - Proceedings of the …, 2021 - National Acad Sciences
Multiple sclerosis (MS), a putative autoimmune disease of the central nervous system (CNS),
commonly presents as relapsing-remitting MS (RRMS), characterized by recurrent episodes …
commonly presents as relapsing-remitting MS (RRMS), characterized by recurrent episodes …
Cytotoxic B Cells in relapsing-remitting multiple sclerosis patients
VO Boldrini, AM Marques, RPS Quintiliano… - Frontiers in …, 2022 - frontiersin.org
Background Emerging evidence of antibody-independent functions, as well as the clinical
efficacy of anti-CD20 depleting therapies, helped to reassess the contribution of B cells …
efficacy of anti-CD20 depleting therapies, helped to reassess the contribution of B cells …
Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF
C Malmeström, J Lycke, S Haghighi, O Andersen… - Journal of …, 2008 - Elsevier
MS is thought to be mediated by CD4+ T-helper cells. To investigate the importance of CD8+
cytotoxic T-cells in MS we analyzed peripheral blood T-cells by DNA microarray, and plasma …
cytotoxic T-cells in MS we analyzed peripheral blood T-cells by DNA microarray, and plasma …
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells
N Benallegue, B Nicol, J Lasselin, S Bézie… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Multiple sclerosis (MS) is a chronic inflammatory and
demyelinating disease of the CNS. Studies of immune dysfunction in MS have mostly …
demyelinating disease of the CNS. Studies of immune dysfunction in MS have mostly …
Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
PJ Liu, TT Yang, ZX Fan, GB Yuan, L Ma… - Frontiers in …, 2023 - frontiersin.org
Background Increasing evidence indicates the importance of CD8+ T cells in autoimmune
attack against CNS myelin and axon in multiple sclerosis (MS). Previous research has also …
attack against CNS myelin and axon in multiple sclerosis (MS). Previous research has also …
Distinct T cell signatures define subsets of patients with multiple sclerosis
MC Johnson, ER Pierson, AJ Spieker… - Neurology …, 2016 - AAN Enterprises
Objective: We investigated T cell responses to myelin proteins in the blood of healthy
controls and 2 groups of patients with relapsing-remitting multiple sclerosis (RRMS) who …
controls and 2 groups of patients with relapsing-remitting multiple sclerosis (RRMS) who …
Differential Runx3, Eomes, and T‐bet expression subdivides MS‐associated CD4+ T cells with brain‐homing capacity
C Hoeks, F Puijfelik, SC Koetzier, J Rip… - European Journal of …, 2024 - Wiley Online Library
Multiple sclerosis (MS) is a common and devastating chronic inflammatory disease of the
CNS. CD4+ T cells are assumed to be the first to cross the blood–central nervous system …
CNS. CD4+ T cells are assumed to be the first to cross the blood–central nervous system …
Expansion of neutrophils and classical and nonclassical monocytes as a hallmark in relapsing-remitting multiple sclerosis
D Haschka, P Tymoszuk, G Bsteh, V Petzer… - Frontiers in …, 2020 - frontiersin.org
Neutrophils and monocytes encompassing the classical, intermediate, and nonclassical
population constitute the majority of circulating myeloid cells in humans and represent the …
population constitute the majority of circulating myeloid cells in humans and represent the …
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
E D'Amico, A Zanghì, NL Parrinello, A Romano… - Frontiers in …, 2022 - frontiersin.org
Objectives Using flow cytometry, we characterized myeloid, B, and T cells in patients
recently diagnosed with relapsing–remitting multiple sclerosis (RRMS) naive to disease …
recently diagnosed with relapsing–remitting multiple sclerosis (RRMS) naive to disease …